Indefinite Delivery Contract 75F40126D00010
Award Date 9/30/26
Last Date to Order 9/29/31
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Pricing Type
Labor Hours
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Food and Drug Administration awarded an Indefinite Delivery Contract to Integrated Behavioral Health, Inc. with a ceiling of $8,500,000 on September 30, 2026. This is a multiple-award vehicle, with the FDA anticipating a maximum of two IDIQs under this solicitation. The contract supports Non-Medical Use (NMU) Surveillance services, delivering post-marketing surveillance data reporting and analysis on prescription and over-the-counter drug nonmedical use, illicit substance use, and emerging...
- The federal contract IDV award, valued up to $10 million, was issued by the U.S. Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a U.S. local/state government entity and healthcare provider. The contract provides data resources to support the FDA's post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug use. Under this IDV, Denver Health has been awarded multiple firm fixed-price delivery orders. These include a $205,010...
- The Food and Drug Administration awarded a single-award indefinite-delivery contract to Source Healthcare Analytics LLC with a ceiling of $45 million on May 22, 2020, to provide access to outpatient prescription and patient-level drug utilization data supporting the agency's drug safety monitoring efforts. The contract has no set-aside designation and is structured as a firm fixed-price vehicle with a completion date of May 21, 2025. Work is performed in Penllyn, Pennsylvania. The IDIQ...
- The Food and Drug Administration (FDA) has awarded a $45 million single-award Indefinite Delivery Contract (IDC) to Source Healthcare Analytics LLC for the "ACCESS TO OUTPATIENT LONGITUDINAL DATA IDIQ" over a 5-year period ending in May 2025. The purpose of this contract is to procure real-world data to aid the FDA in monitoring drug safety and effectiveness. Under this IDC, the FDA has issued Task Order 1, valued at $13,119,440, to Source Healthcare Analytics LLC for the...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
- The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
- This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...
- The Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Contract to Syneos Health Research & Insights LLC on May 16, 2023, with a contract ceiling value of $3.4 million and a performance period extending through May 16, 2027. The contract was awarded without a set-aside restriction and originated from a competitive solicitation posted on March 13, 2023, with proposals due on April 17, 2023. Under this indefinite delivery vehicle, Syneos Health Research &...